Evaluation of a polyvalent enzyme-linked immunosorbent assay incorporating a recombinant p44 antigen for diagnosis of granulocytic ehrlichiosis in dogs and horses.

This research study aimed to evaluate the efficiency of a polyvalent enzyme-linked immunosorbent assay (ELISA) which used a specific p44 antigen, in diagnosing granulocytic ehrlichiosis in dogs and horses. The researchers concluded that this ELISA test was suitable for detecting antibodies associated with the disease.

Research Methodology

• 32 dogs and 43 horses were involved in the study, with tests being conducted on serum samples.
• The polyvalent ELISA test, which used a specific recombinant antigen called p44, was developed and applied.
• The results from this ELISA test were compared with the results from indirect fluorescent antibody (IFA) staining and western immunoblotting – both methods that also detect the presence of specific antibodies.

Results

• In both canine and equine samples, percentages of samples with positive results were similar across the ELISA test, IFA staining, and western immunoblotting.
• Complete agreement – i.e., the same result – across all three tests was found in 91% of canine samples (29 out of 32) and 70% of equine samples (30 out 43).
• However, there were some samples that had known antibodies to specific Ehrlichia species (E. canis in dogs, E. risticii in horses) which the polyvalent ELISA did not detect.

Conclusions

• The overall findings suggest that the polyvalent ELISA incorporating a recombinant p44 antigen is quite effective in detecting antibodies to E. equi (which causes granulocytic ehrlichiosis) in dogs and horses.
• The research also demonstrated some discrepancies in ELISA results with samples with known antibodies to certain Ehrlichia species. This might indicate potential improvement areas for the test sensitivity and specificity, or suggest species-specific variations in detecting antibodies that need further research.